Suppr超能文献

58例采用组氨酸限制饮食治疗的组氨酸血症患者的长期随访:治疗无效。

Long-term follow-up of 58 patients with histidinemia treated with a histidine-restricted diet: no effect of therapy.

作者信息

Widhalm K, Virmani K

机构信息

Department of Pediatrics, University of Vienna, Austria.

出版信息

Pediatrics. 1994 Dec;94(6 Pt 1):861-6.

PMID:7971002
Abstract

OBJECTIVE

There is no general agreement as to whether or not patients with histidinemia should be treated with a histidine-restricted diet because the majority of the patients are asymptomatic. Between April 1969 and December 1986 124 children with histidinemia were detected in the Austrian Neonates Screening Program and they received long-term follow-up.

DESIGN

Fifty nine patients were treated with a histidine-restricted diet (35 mg/kg). The follow-up included determining biochemical parameters, physical examination and psychological assessment of 58 treated and 43 untreated patients. After termination of the Screening Program information about the patients' development was obtained through questionnaires and follow-up of 20 patients aged 11 to 17 years.

RESULTS

Histidine blood levels decreased after institution of the diet, but rose again after termination of the died. In the untreated patients histidine levels were highest at 1 year of age, decreasing with age. When the IQ scores of the treated and the untreated group were compared, significantly higher IQ scores were found in the 4-year-old and 6-year-old untreated patients (P < .05). Clinical symptoms were found in 27 patients; treated and untreated patients were equally affected. The clinical observations included speech defects, psychomotor and general retardation, emotional disturbances, recurrent respiratory infections, and miscellaneous symptoms such as atopic dermatitis.

CONCLUSION

We conclude that patients with histidinemia do not benefit from dietary treatment.

摘要

目的

对于组氨酸血症患者是否应采用限制组氨酸饮食进行治疗,目前尚无普遍共识,因为大多数患者并无症状。在1969年4月至1986年12月期间,奥地利新生儿筛查项目中检测出124例组氨酸血症患儿,并对他们进行了长期随访。

设计

59例患者采用限制组氨酸饮食(35毫克/千克)进行治疗。随访包括对58例接受治疗和43例未接受治疗的患者进行生化参数测定、体格检查和心理评估。在筛查项目结束后,通过问卷调查和对20例11至17岁患者的随访,获取了有关患者发育情况的信息。

结果

饮食治疗后组氨酸血水平下降,但饮食结束后又再次上升。在未接受治疗的患者中,组氨酸水平在1岁时最高,随后随年龄增长而下降。比较接受治疗组和未接受治疗组的智商得分时,发现4岁和6岁未接受治疗的患者智商得分显著更高(P <.05)。27例患者出现临床症状;接受治疗和未接受治疗的患者受影响程度相同。临床观察结果包括言语缺陷、精神运动和整体发育迟缓、情绪障碍、反复呼吸道感染以及特应性皮炎等各种症状。

结论

我们得出结论,组氨酸血症患者无法从饮食治疗中获益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验